Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom

BACKGROUND: Several bone-targeted agents (BTAs) are available for preventing skeletal-related events (SREs), but they vary in terms of efficacy, safety and mode of administration. This study assessed data on European physicians’ treatment preferences for preventing SREs in patients with bone metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Yi, Arellano, Jorge, Gatta, Francesca, Hechmati, Guy, Hauber, A. Brett, Mohamed, Ateesha F., Bahl, Amit, von Moos, Roger, Body, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030781/
https://www.ncbi.nlm.nih.gov/pubmed/29970078
http://dx.doi.org/10.1186/s12913-018-3272-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030781/
https://www.ncbi.nlm.nih.gov/pubmed/29970078
http://dx.doi.org/10.1186/s12913-018-3272-x

Ejemplares similares